Best Stocks Under $20 To Buy In 2023
paymentsDiscover value opportunities among Stocklytics' Best Stocks Under $20 to Buy in 2023, offering affordable stocks with potential for growth. These picks combine affordability with potential for appreciation, catering to investors seeking options under $20 per share. Stocklytics focuses on undervalued stocks trading below $20, indicating potential for upward movement. Whether you're looking for bargain opportunities or aiming to diversify your portfolio, Stocklytics' selections offer a diverse range of stocks positioned for potential appreciation in the coming year.
| name | Price | $ Change | % Change | Market Cap | Score language | Tags | Volume | Avg. Volume | Technicals | Dividend Y | ROI 1Y | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLNNClene | $2.30 | -$0.11 | arrow_drop_down4.48% | $23.17M | High Growth | 136.44K | 2.36 | Neutralremove | - | -68.34% | |||||
 HPHelmerich & Payne | $15.55 | -$0.03 | arrow_drop_down0.19% | $1.80B | - | 1.41M | 15.48 | Neutralremove | 3.77% | -58.46% | |||||
PYPDPolyPid Ltd | $2.77 | -$0.02 | arrow_drop_down0.71% | $29.04M | High Growth | 12.34K | 2.80 | Neutralremove | - | -40.49% | |||||
KROKronos Worldwide | $6.56 | -$0.12 | arrow_drop_down1.79% | $799.50M | - | 138.56K | 6.53 | Neutralremove | 2.29% | -49.80% | |||||
HCSGHealthcare Services Group | $14.27 | $0.02 | arrow_drop_up0.17% | $1.05B | - | 309.13K | 14.27 | Neutralremove | - | 25.77% | |||||
CATXPerspective Therapeutics, Inc. Common Stock | $2.43 | -$0.07 | arrow_drop_down2.98% | $178.89M | Penny Stock | 398.11K | 2.50 | Neutralremove | - | -83.65% | |||||
MVBFMVB Financial | $18.99 | -$0.02 | arrow_drop_down0.10% | $242.09M | - | 82.31K | 18.95 | Neutralremove | 3.68% | 0.87% | |||||
TNGXTango Therapeutics | $1.84 | -$0.00 | arrow_drop_down0.26% | $164.75M | Penny Stock | 1.99M | 1.91 | Neutralremove | - | -75.04% | |||||
GDYNGrid Dynamics Holdings | $12.95 | -$0.12 | arrow_drop_down0.91% | $1.21B | - | 455.11K | 12.99 | Neutralremove | - | 28.39% | |||||
UDMYUdemy | $6.86 | $0.05 | arrow_drop_up0.73% | $1.05B | - | 517.26K | 6.89 | Neutralremove | - | -27.35% | |||||
RXRXRecursion Pharmaceuticals | $4.08 | -$0.02 | arrow_drop_down0.60% | $1.72B | - | 13.86M | 4.08 | Neutralremove | - | -56.35% | |||||
KREF KREFKKR Real Estate Finance Trust | $9.00 | $0.14 | arrow_drop_up1.57% | $646.87M | - | 313.17K | 8.94 | Neutralremove | 9.02% | -7.06% | |||||
BBDCBarings BDC | $9.06 | $0.06 | arrow_drop_up0.66% | $937.85M | - | 202.84K | 9.04 | Neutralremove | 9.98% | -7.50% | |||||
RCATRed Cat Holdings | $6.90 | $0.12 | arrow_drop_up1.78% | $590.04M | - | 3.67M | 6.79 | Neutralremove | - | 528.00% | |||||
PXP10 | $11.23 | $0.03 | arrow_drop_up0.31% | $1.36B | - | 326.63K | 11.22 | Neutralremove | 1.10% | 36.61% | |||||
ORGOOrganogenesis Holdings | $2.93 | -$0.03 | arrow_drop_down1.17% | $384.36M | Penny Stock | 349.64K | 2.94 | Neutralremove | - | 4.07% | |||||
EBSEmergent BioSolutions | $6.37 | -$0.11 | arrow_drop_down1.76% | $297.98M | High Growth | 787.37K | 6.35 | Neutralremove | - | 26.97% | |||||
BBarnes Group | $19.05 | $0.39 | arrow_drop_up2.08% | $30.86B | - | 8.73M | 19.00 | Neutralremove | 1.35% | -53.08% | |||||
 AMCAMC Entertainment Holdings | $3.22 | -$0.00 | arrow_drop_down0.15% | $1.21B | Penny Stock | 12.66M | 3.22 | Sellkeyboard_arrow_down | - | -36.26% | |||||
VETVermilion Energy | $6.38 | $0.03 | arrow_drop_up0.54% | $1.04B | - | 1.26M | 6.36 | Neutralremove | 3.58% | -47.83% |
Showing 681-700 of 742
Results per page:
About Best Stocks Under $20 To Buy In 2023
Discover value opportunities among Stocklytics' Best Stocks Under $20 to Buy in 2023, offering affordable stocks with potential for growth. These picks combine affordability with potential for appreciation, catering to investors seeking options under $20 per share. Stocklytics focuses on undervalued stocks trading below $20, indicating potential for upward movement. Whether you're looking for bargain opportunities or aiming to diversify your portfolio, Stocklytics' selections offer a diverse range of stocks positioned for potential appreciation in the coming year.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools